Evidence map›Paper›PMID 33154441›Full record

ArticleScientific reports2020

A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.

Francesco Nannini, Farhaan Parekh, Patrycja Wawrzyniecka, Leila Mekkaoui, Matteo Righi, Fatemeh V Dastjerdi, Jenny Yeung, Claire Roddie, Yuchen Bai, Biao Ma and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Construction of Naïve and Immune Human Fab Phage Display Library.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Review
  3. Construction of Naïve and Immune Human Fab Phage Display Library.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Francesco NanniniResearch Department of Haematology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Farhaan ParekhResearch Department of Haematology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Patrycja WawrzynieckaResearch Department of Haematology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Leila MekkaouiResearch Department of Haematology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Matteo RighiResearch Department of Haematology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Fatemeh V DastjerdiResearch Department of Oncology, UCL Cancer Institute, London, UK.
Jenny YeungResearch Department of Oncology, UCL Cancer Institute, London, UK.
Claire RoddieResearch Department of Haematology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK.
Yuchen BaiAutolus Therapeutics, London, UK.
Biao MaAutolus Therapeutics, London, UK.
Mathieu FerrariAutolus Therapeutics, London, UK.
Shimobi OnuohaAutolus Therapeutics, London, UK.
Kerry ChesterResearch Department of Oncology, UCL Cancer Institute, London, UK.
Martin PuleResearch Department of Haematology, UCL Cancer Institute, 72 Huntley Street, London, WC1E 6DD, UK. martin.pule@ucl.ac.uk.
CRUK Lung Cancer Centre of Excellence · GBAutolus (United Kingdom) · GBUniversity College London · GB

Funding

Cancer Research UK 17658Cancer Research UK 515707Department of Health
6 · The paper itself

Abstract

Antibody phage display is a powerful platform for discovery of clinically applicable high affinity monoclonal antibodies against a broad range of targets. Libraries generated from immunized animals offer the advantage of in vivo affinity-maturation of V regions prior to library generation. Despite advantages, few studies have described isolation of antibodies from rats using immune phage display. In our study, we describe a novel primer set, covering the full rat heavy chain variable and kappa light chain variable regions repertoire for the generation of an unbiased immune libraries. Since the immune repertoire of rats is poorly understood, we first performed a deep sequencing analysis of the V(D)J regions of VH and VLK genes, demonstrating the high abundance of IGVH2 and IGVH5 families for VH and IGVLK12 and IGVLK22 for VLK. The comparison of gene's family usage in naïve rats have been used to validate the frequency's distribution of the primer set, confirming the absence of PCR-based biases. The primers were used to generate and assemble a phage display library from human CD160-vaccinated rats. CD160 represents a valid therapeutic target as it has been shown to be expressed on chronic lymphocytic leukaemia cells and on the surface of newly formed vessels. We utilised a novel phage display panning strategy to isolate a high affinity pool (KD range: 0.399-233 nM) of CD160 targeting monoclonal antibodies. Subsequently, identified binders were tested for function as third generation Chimeric Antigen Receptors (CAR) T cells demonstrating specific cytolytic activity. Our novel primer set coupled with a streamlined strategy for phage display panning enable the rapid isolation and identification of high affinity antibodies from immunised rats. The therapeutic utility of these antibodies was demonstrated in CAR format.

Indexed as

ImmunizationAnimalsAntibodies, MonoclonalAntigens, SurfaceCell Surface Display TechniquesRatsSingle-Chain AntibodiesAntibodies, MonoclonalAntigens, SurfaceSingle-Chain Antibodies

Identifiers

PMID33154441
PMCPMC7644676
OpenAlexW3097419098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.